Navigation Links
Melbourne Cluster Of Brain Tumour Not Due To Radiation From Phone Towers

Stating that there is no evidence to blame phones towers, the chief executive of the Cancer Council Australia, Alan Coates, has stated that chance// is a more likely explanation for the Melbourne cluster of brain tumours than radiation from mobile phones or any other environmental exposure. .

Professor Coates explained that the cluster of disease happen by chance, he said that there is usually no cause every time they happen though we look for any specific reasons. .

While explaining that there have been extensive surveys but no definitive link between the low levels of electromagnetic energy generated by mobile phones and base station towers and the development of cancer or other diseases, he said that a possible link had not been completely disproved yet. .

He explained that it was reasonable to take the precaution of evacuating the building to reassure workers while testing was undertaken. But he was of the opinion that given the high concentration of mobile-phone antennae throughout Australia and other developed countries, many brain tumour clusters would be expected if radiation were responsible. .

Professor Coates explained that benign brain tumours especially the five of the seven cases detected would typically take many years or even decades to develop to the point of detection. So he felt that the Melbourne workers' condition might have predated their exposure to the phone towers. But he did caution that aggressive, malignant tumours could develop in weeks or months. .


'"/>




Page: 1

Related medicine news :

1. Melbourne at cutting edge of fight to find bird flu vaccine
2. Melbourne University Launches Plan To Produce More Caring Doctors
3. Cluster Headaches Can Be Treated By Nasal Spray
4. Use of Cellular Phones associated with Increased risk of Brain Tumors
5. Brain death – How to cope with it
6. “Brain fingerprinting”- The new lie detectr
7. Nasal Spray Could Take Drugs Direct to Brain.
8. Virus Combats Brain Tumour
9. Nasal Spray Could Take Drugs Directly to Brain
10. Control of anger disorder connected to Brain Dysfunction
11. High Levels of Protein Linked to Brain Shrinkage
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/22/2017)... Peoria, IL (PRWEB) , ... May 22, 2017 ... ... HealthCare, is part of a larger group investing in InsightRX, an early stage ... a patient’s underlying biological and pharmacological characteristics. Greatpoint Ventures Innovation Fund ...
(Date:5/21/2017)... FL (PRWEB) , ... May 20, 2017 , ... Pot. ... it, find it, review it, and share its attributes like never before. More than ... directory to connect cannabis enthusiasts to stores, strains, products – and for the first ...
(Date:5/21/2017)... ... May 21, 2017 , ... ... longer than six months since you've seen a dentist, it's time for a ... and getting x-rays once per year. , Dental checkups are a relatively easy ...
(Date:5/19/2017)... ... May 19, 2017 , ... Springfield, Vermont-based law firm ... Titled " Ten Good Reasons To Hire An Experienced Personal Injury Attorney, " the ... an accident or injury. As the article says. if someone is injured due ...
(Date:5/19/2017)... ... 19, 2017 , ... As a groundbreaking surgeon on the frontline of prostate ... screenings. Early detection of the disease, he says, can make a world of difference. ... , stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate Cancer Task Force and ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)...  As the specialty pharmacy industry and the ... the revolutionary shift from volume-based to value-based care, ... patient outcomes and shaping the future of the ... from clinical trials and toward data that reveals ... therapy utilization in precise patient populations. Therigy ® ...
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/15/2017)... 2017 Enterin Inc., a privately-held CNS pharmaceutical company ... compounds to treat Parkinson,s disease (PD), has enrolled the first ... 1/2a randomized, controlled, multicenter study involving patients with PD and ... patients over a 9-to-12-month period. The first stage is open ... PD. Participating sites include Denver , ...
Breaking Medicine Technology: